| ATP5F1B Protein |
|---|
| Gene | ATP5F1B (ATP Synthase Subunit Beta) |
| UniProt ID | P06576 |
| Alternative Names | ATP synthase subunit beta, ATPB, ATPMB |
| PDB Structures | 1BM1, 2CW4, 5ARA |
| Molecular Weight | ~56 kDa |
| Subcellular Localization | Mitochondrial inner membrane |
| Protein Family | F-type ATP synthase, H+-transporting ATPase complex |
ATP5F1B (ATP Synthase Subunit Beta, encoded by the ATP5F1B gene) is the catalytic beta subunit of the mitochondrial F1 sector of ATP synthase (Complex V), the terminal enzyme of the oxidative phosphorylation (OXPHOS) chain. This protein catalyzes the conversion of ADP and inorganic phosphate (Pi) to ATP using the proton gradient generated by the electron transport chain. In the nervous system, ATP5F1B is essential for maintaining neuronal energy homeostasis, and its dysfunction is implicated in Alzheimer's disease, Parkinson's disease, ALS, and other neurodegenerative disorders [@lin2005].
ATP5F1B is the catalytic core of the F1-ATPase complex. The protein contains several structurally and functionally distinct domains:
¶ Catalytic Domains
The beta subunit contains the catalytic machinery for ATP synthesis:
- Nucleotide binding domain: Binds ADP and ATP at three catalytic sites
- Rotation transmission domain: Couples rotation to proton translocation
- Central stalk interface: Interfaces with the gamma subunit to transmit rotation
- Oligomycin sensitivity conferral site: Region conferring oligomycin sensitivity to the complex
Crystal structures reveal a hexameric arrangement of alternating alpha and beta subunits:
- Alpha-beta hexamer: Six subunits (3 alpha, 3 beta) forming a ring
- Rotational catalysis: Beta subunit undergoes conformational changes during rotation
- Central stalk: Gamma subunit rotates within the alpha/beta hexamer
ATP5F1B is highly conserved across eukaryotes, reflecting its essential role in energy metabolism.
ATP5F1B is central to mitochondrial oxidative phosphorylation, the primary mechanism for ATP production in aerobic cells:
The beta subunit catalyzes the final step in oxidative phosphorylation:
- Proton gradient: Electron transport chain pumps protons across the inner membrane
- F0 channel: Protons flow back through the F0 sector
- Rotational coupling: Proton flow drives rotation of the gamma subunit
- Conformational change: Beta subunit transitions through three states
- ATP release: Conformational change releases newly synthesized ATP
Each glucose molecule yields approximately 30-32 ATP through oxidative phosphorylation:
- Glycolysis: 2 ATP
- Krebs cycle: 2 ATP
- Oxidative phosphorylation: ~28 ATP
The beta subunit is regulated at multiple levels:
- Transcriptional control: Nuclear、呼吸链and mitochondria-encoded subunits coordinated
- Post-translational modification: Phosphorylation affects activity
- Product inhibition: ATP:ADP ratio feedback inhibits activity
- Calcium regulation: Ca2+ influences mitochondrial ATP production
ATP5F1B works in concert with other Complex V subunits:
- F0 sector: Proton channel (subunits a, A6L, b, c-ring)
- F1 sector: Catalytic core (alpha3beta3, gamma, delta, epsilon)
- Peripheral stalk: Stabilizes the complex
- OSCP: Oligomycin sensitivity conferral protein
In neurons, ATP5F1B is critical for maintaining energy homeostasis in highly energy-demanding cells:
Neurons have exceptionally high energy demands:
- Resting potential: Maintaining ion gradients requires constant ATP
- Action potentials: Regeneration requires ATP-dependent pumps
- Synaptic transmission: Neurotransmitter release is ATP-intensive
- Axonal transport: ATP powers molecular motors
- Protein synthesis: Local translation at synapses
ATP5F1B is highly expressed in:
- Cerebral cortex (pyramidal neurons)
- Hippocampus (CA1 pyramidal neurons)
- Cerebellum (Purkinje cells)
- Substantia nigra (dopaminergic neurons)
- Spinal cord (motor neurons)
ATP5F1B supports specialized neuronal functions:
- Synaptic vesicle cycling: ATP for vesicle release/recycling
- Dendritic spines: High energy demand for plasticity
- Axonal mitochondria: Energy for transport
- Presynaptic terminals: Dense mitochondrial networks
Mitochondrial dysfunction is a hallmark of AD, with ATP5F1B playing a central role [@ryan2012]:
- Reduced Complex V activity: ATP synthase activity decreases in AD brain
- Amyloid-beta interaction: Aβlocalizes to mitochondria and impairs function
- Tau pathology: Affects mitochondrial transport and distribution
- Bioenergetic deficits: Reduced ATP production in neurons
- Calcium dysregulation: Impaired mitochondrial Ca2+ handling
ATP5F1B is particularly relevant to PD pathogenesis [@perier2012]:
- Dopaminergic neuron vulnerability: High energy demand makes these neurons susceptible
- Mitochondrial Complex I deficiency: Often accompanied by Complex V defects
- LRRK2 mutations: Affect mitochondrial dynamics and function
- PINK1/Parkin pathway: Links mitophagy to bioenergetic defects
- Alpha-synuclein: May impair mitochondrial function directly
ATP5F1B contributes to motor neuron degeneration [@bhattacharya2014]:
- Energy deficit: Reduced ATP production in motor neurons
- Mitochondrial dysfunction: Common feature in ALS models
- Axonal transport defects: Impaired organelle trafficking
- C9orf72 repeat toxicity: Affects mitochondrial function
- TDP-43 pathology: Disrupts mitochondrial protein homeostasis
- Mutant huntingtin disrupts mitochondrial function
- ATP5F1B expression altered in HD models
- Bioenergetic deficits contribute to neuronal dysfunction
- Friedreich's ataxia: Frataxin deficiency affects Complex V
- Leigh syndrome: Mitochondrial ATP production defective
- MELAS: Mitochondrial encephalomyopathy with lactic acidosis
Multiple mechanisms link ATP5F1B to neurodegeneration:
- Direct dysfunction: Mutations or post-translational modifications
- Indirect impairment: Downstream effects of other defects
- Transport defects: Reduced mitochondrial distribution
- Quality control: Impaired mitochondrial biogenesis
ATP5F1B dysfunction affects calcium handling:
- Reduced Ca2+ uptake: ATP-dependent transporters affected
- Excitotoxicity: Impaired buffer capacity
- Synaptic dysfunction: Calcium-dependent plasticity impaired
Mitochondrial dysfunction increases oxidative stress:
- Electron leak: Increased ROS from ETC
- Direct ROS damage: To proteins, lipids, DNA
- Peroxynitrite formation: Nitrosative stress
- Mitochondrial CoQ10: Supports electron transport
- L-carnitine: Enhances fatty acid oxidation
- Alpha-lipoic acid: Antioxidant and metabolic support
- mTOR inhibitors: May improve mitochondrial function [@johnson2010]
- AMPK activators: Promote mitochondrial biogenesis
- NAD+ precursors: Support sirtuin activity
- ATP5F1B overexpression: Enhance ATP production
- Mitochondrial targeting: Improve distribution
- CRISPR activation: Upregulate functional expression
- ATP synthase activators: Enhance catalytic function
- Mitochondrial protectants: Reduce oxidative damage
- Biogenesis promoters: Increase mitochondrial mass
- Metabolic modulators: Optimize substrate utilization
¶ Mermaid Diagram: ATP5F1B in Neuronal Energy and Neurodegeneration
flowchart TD
A["Glucose<br/>Pyruvate"] --> B["Krebs<br/>Cycle"]
B --> C["Electron Transport<br/>Chain"]
C --> D["Proton<br/>Gradient"]
D --> E["ATP Synthase<br/>F0F1 Complex"]
E --> F["ATP5F1B<br/>Beta Subunit"]
F --> G["ATP<br/>Production"]
H["Neuronal Function"] --> I["Ion<br/>Gradients"]
H --> J["Synaptic<br/>Transmission"]
H --> K["Axonal<br/>Transport"]
I --> L["Resting<br/>Potential"]
J --> M["Neurotransmitter<br/>Release"]
K --> N["Organelle<br/>Movement"]
O["Disease States"] --> P["AD/PD/ALS"]
P --> Q["ATP Synthesis<br/>Deficits"]
Q --> R["Bioenergetic<br/>Failure"]
R --> S["Neuronal<br/>Death"]
T["Therapeutic<br/>Targets"] --> U["Mitochondrial<br/>Protectants"]
T --> V["ATP Synthase<br/>Activators"]
T --> W["Biogenesis<br/>Promoters"]
- Hatefi Y, The mitochondrial electron transport chain and ATP synthase (1985)
- Capaldi RA, et al., Molecular basis of vertebrate mitochondrial metabolism (1988)
- Wallace DC, Mitochondrial genetics: a paradigm for aging and degenerative diseases (1992)
- Bossy-Wetzel E, et al., Mitochondria in neurodegeneration (1998)
- Mattson MP, et al., Mitochondria in neuronal survival and death (1999)
- Lin MT, Beal MF, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases (2006)
- Sayre LM, et al., Iron and aluminum in neurodegenerative diseases (2000)
- Perier C, et al., Mitochondrial bioenergetics in Parkinson's disease (2012)
- Ryan T, et al., Mitochondria and Alzheimer's disease (2012)
- Bhattacharya K, et al., Mitochondrial dysfunction in ALS (2014)
- Van Leene J, et al., The Arabidopsis mitochondrial proteome (2011)
- Johnson SC, et al., mTOR inhibition induces oxidative stress and improves brain function (2010)
- Manji H, et al., Mitochondrial dysfunction in mood disorders (2012)
- Schon EA, Przyborski SA, Mitochondria and neurodegeneration: the plot thickens (2012)
- Devin A, et al., Bioenergetic analysis of mitochondrial function (2010)
- Taylor RC, et al., Quality control in mitochondrial protein synthesis (2013)
- Zhang X, et al., Mitochondrial ATP synthase in aging and longevity (2015)
- Vafai SB, et al., Mitochondrial disorders and the nervous system (2016)
- Strobelt S, et al., Mitochondrial ATP synthase in synaptic plasticity (2020)
- Moreno JA, et al., Targeting mitochondrial ATP synthase in neurodegenerative disease (2021)